Nuveen’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05B | Buy |
8,336,930
+503,366
| +6% | +$66.3M | 0.25% | 77 |
|
|
2026
Q1 | $1.09B | Buy |
7,833,564
+1,519,508
| +24% | +$213M | 0.3% | 65 |
|
|
2025
Q4 | $775M | Buy |
6,314,056
+368,303
| +6% | +$44.8M | 0.2% | 90 |
|
|
2025
Q3 | $660M | Buy |
5,945,753
+91,500
| +2% | +$10.4M | 0.17% | 103 |
|
|
2025
Q2 | $649M | Buy |
5,854,253
+317,309
| +6% | +$33.8M | 0.18% | 99 |
|
|
2025
Q1 | $620M | Buy |
5,536,944
+328,623
| +6% | +$33.9M | 0.19% | 101 |
|
|
2024
Q4 | $481M | Buy |
5,208,321
+724,493
| +16% | +$65.2M | 0.14% | 128 |
|
|
2024
Q3 | $376M | Sell |
4,483,828
-502,589
| -10% | -$38.3M | 0.11% | 161 |
|
|
2024
Q2 | $342M | Sell |
4,986,417
-3,584,153
| -42% | -$239M | 0.1% | 161 |
|
|
2024
Q1 | $628M | Sell |
8,570,570
-2,964,905
| -26% | -$228M | 0.19% | 109 |
|
|
2023
Q4 | $934M | Buy |
11,535,475
+121,326
| +1% | +$9.44M | 0.3% | 68 |
|
|
2023
Q3 | $855M | Buy |
11,414,149
+1,614,798
| +16% | +$124M | 0.3% | 70 |
|
|
2023
Q2 | $755M | Buy |
9,799,351
+530,242
| +6% | +$42.3M | 0.26% | 79 |
|
|
2023
Q1 | $769M | Buy |
9,269,109
+614,202
| +7% | +$50.9M | 0.29% | 83 |
|
|
2022
Q4 | $743M | Buy |
8,654,907
+663,387
| +8% | +$52.5M | 0.29% | 83 |
|
|
2022
Q3 | $493M | Buy |
7,991,520
+1,123,549
| +16% | +$70.8M | 0.2% | 104 |
|
|
2022
Q2 | $425M | Sell |
6,867,971
-766,659
| -10% | -$47.5M | 0.16% | 127 |
|
|
2022
Q1 | $455M | Sell |
7,634,630
-1,361,924
| -15% | -$87.1M | 0.15% | 135 |
|
|
2021
Q4 | $653M | Sell |
8,996,554
-278,343
| -3% | -$19.2M | 0.19% | 114 |
|
|
2021
Q3 | $648M | Buy |
9,274,897
+407,151
| +5% | +$28.6M | 0.2% | 104 |
|
|
2021
Q2 | $611M | Buy |
8,867,746
+148,891
| +2% | +$9.94M | 0.18% | 114 |
|
|
2021
Q1 | $564M | Buy |
8,718,855
+3,918,666
| +82% | +$253M | 0.18% | 116 |
|
|
2020
Q4 | $280M | Buy |
4,800,189
+55,306
| +1% | +$3.34M | 0.09% | 197 |
|
|
2020
Q3 | $300M | Sell |
4,744,883
-1,626,848
| -26% | -$113M | 0.12% | 170 |
|
|
2020
Q2 | $490M | Sell |
6,371,731
-6,067,783
| -49% | -$465M | 0.2% | 96 |
|
|
2020
Q1 | $930M | Buy |
12,439,514
+4,135,434
| +50% | +$286M | 0.45% | 47 |
|
|
2019
Q4 | $540M | Sell |
8,304,080
-1,512,563
| -15% | -$98.5M | 0.2% | 107 |
|
|
2019
Q3 | $622M | Sell |
9,816,643
-30,716
| -0.3% | -$2.01M | 0.25% | 82 |
|
|
2019
Q2 | $665M | Buy |
9,847,359
+9,094,586
| +1,208% | +$598M | 0.26% | 77 |
|
|
2019
Q1 | $48.9M | Buy |
752,773
+188,180
| +33% | +$12.5M | 0.26% | 73 |
|
|
2018
Q4 | $35.3M | Sell |
564,593
-65,430
| -10% | -$4.57M | 0.22% | 104 |
|
|
2018
Q3 | $48.6M | Buy |
630,023
+4,153
| +0.7% | +$314K | 0.26% | 88 |
|
|
2018
Q2 | $44.3M | Sell |
625,870
-59,721
| -9% | -$4.22M | 0.28% | 86 |
|
|
2018
Q1 | $51.7M | Sell |
685,591
-290,812
| -30% | -$23.1M | 0.34% | 59 |
|
|
2017
Q4 | $70M | Buy |
976,403
+116,003
| +13% | +$8.81M | 0.45% | 42 |
|
|
2017
Q3 | $69.7M | Buy |
860,400
+152,293
| +22% | +$11.6M | 0.46% | 42 |
|
|
2017
Q2 | $50.1M | Buy |
708,107
+10,669
| +2% | +$710K | 0.32% | 65 |
|
|
2017
Q1 | $47.4M | Sell |
697,438
-96,733
| -12% | -$6.8M | 0.28% | 84 |
|
|
2016
Q4 | $56.9M | Buy |
794,171
+133,289
| +20% | +$9.91M | 0.29% | 80 |
|
|
2016
Q3 | $52.3M | Sell |
660,882
-37,966
| -5% | -$3.08M | 0.31% | 78 |
|
|
2016
Q2 | $58.3M | Sell |
698,848
-57,810
| -8% | -$5.13M | 0.36% | 61 |
|
|
2016
Q1 | $69.5K | Buy |
756,658
+33,092
| +5% | +$2.98M | 0.36% | 46 |
|
|
2015
Q4 | $73.2K | Sell |
723,566
-184
| -0% | -$19.1K | 0.38% | 41 |
|
|
2015
Q3 | $71.1K | Sell |
723,750
-17,918
| -2% | -$1.99M | 0.4% | 40 |
|
|
2015
Q2 | $86.8K | Sell |
741,668
-4,225
| -0.6% | -$462K | 0.47% | 31 |
|
|
2015
Q1 | $73.2M | Sell |
745,893
-25,639
| -3% | -$2.6M | 0.4% | 43 |
|
|
2014
Q4 | $72.7M | Buy |
771,532
+107,869
| +16% | +$11.2M | 0.41% | 42 |
|
|
2014
Q3 | $70.6M | Sell |
663,663
-29,920
| -4% | -$2.93M | 0.43% | 44 |
|
|
2014
Q2 | $57.5M | Sell |
693,583
-147,692
| -18% | -$11.5M | 0.35% | 55 |
|
|
2014
Q1 | $59.6M | Buy |
841,275
+16,036
| +2% | +$1.26M | 0.36% | 47 |
|
|
2013
Q4 | $62M | Sell |
825,239
-143,109
| -15% | -$9.96M | 0.4% | 44 |
|
|
2013
Q3 | $60.9M | Sell |
968,348
-88,606
| -8% | -$5.3M | 0.39% | 52 |
|
|
2013
Q2 | $54.2M | Buy |
+1,056,954
| New | +$55.1M | 0.36% | 51 |
|
Other funds holding GILD
Nuveen's GILD Position: Q2 2026 in Review
Nuveen increased its Gilead Sciences (GILD) stake by 6.4% in Q2 2026, buying an estimated $66.3M and bringing the position to 8,336,930 shares worth $1.05B. The position accounts for 0.25% of the portfolio, ranked #77.
Nuveen first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.09B in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Nuveen held 8,336,930 shares of Gilead Sciences worth $1.05B as of Q2 2026.
- Nuveen bought 503,366 Gilead Sciences shares in Q2 2026, an estimated $66.3M.
- Gilead Sciences made up 0.25% of Nuveen's portfolio in Q2 2026, its #77 holding.
- Nuveen first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Nuveen's Gilead Sciences position peaked at $1.09B in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.